drugset / Trial / NCT00294892

Pharmacokinetics Study on Nevirapine Resistance in Tanzania

NCT00294892

Phase 2 Completed 144 enrolled Radboud University Medical Center
RandomizedParallel-groupOpen-labelTreatment

Summary

Primary * pharmacokinetics of single dose nevirapine * the effect of single dose carbamazepine on the pk of single dose nevirapine * resistance against nevirapine before and after. * follow-up on HIV status newborns * relation between nevirapine levels in cord blood and plasma Secondary \* safety of single dose nevirapine and nevirapine/carbamazepine Hypothesis: Single dose carbamazepine decreases development of resistance to nevirapine in HIV positive pregnant Tanzanian women by decreasing nevirapine half-life.

Timeline

Start
2006-02
Primary completion
2009-09
Completion
2010-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Carbamazepine Small molecule 400 mg Oral
Comparator Nevirapine Small molecule 200 mg Oral